CONCLUSION: Participants with attention-deficit/hyperactivity disorder who took a morning dose of DXR showed a pattern of behavior during simulated driving that was consistent with improved safety-margin behavior (greater time-to-collision) and less abrupt braking responses within the simulation context at 10 h postdose.
